These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28195728)
1. Room Temperature Neutron Crystallography of Drug Resistant HIV-1 Protease Uncovers Limitations of X-ray Structural Analysis at 100 K. Gerlits O; Keen DA; Blakeley MP; Louis JM; Weber IT; Kovalevsky A J Med Chem; 2017 Mar; 60(5):2018-2025. PubMed ID: 28195728 [TBL] [Abstract][Full Text] [Related]
2. Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I. Pawar S; Wang YF; Wong-Sam A; Agniswamy J; Ghosh AK; Harrison RW; Weber IT Biochem Biophys Res Commun; 2019 Jun; 514(3):974-978. PubMed ID: 31092330 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance. Hong L; Zhang XC; Hartsuck JA; Tang J Protein Sci; 2000 Oct; 9(10):1898-904. PubMed ID: 11106162 [TBL] [Abstract][Full Text] [Related]
4. High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains. Tie Y; Boross PI; Wang YF; Gaddis L; Hussain AK; Leshchenko S; Ghosh AK; Louis JM; Harrison RW; Weber IT J Mol Biol; 2004 Apr; 338(2):341-52. PubMed ID: 15066436 [TBL] [Abstract][Full Text] [Related]
5. Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex. Liu Z; Yedidi RS; Wang Y; Dewdney TG; Reiter SJ; Brunzelle JS; Kovari IA; Kovari LC Biochem Biophys Res Commun; 2013 Feb; 431(2):232-8. PubMed ID: 23313846 [TBL] [Abstract][Full Text] [Related]
6. Capturing the reaction pathway in near-atomic-resolution crystal structures of HIV-1 protease. Shen CH; Tie Y; Yu X; Wang YF; Kovalevsky AY; Harrison RW; Weber IT Biochemistry; 2012 Oct; 51(39):7726-32. PubMed ID: 22963370 [TBL] [Abstract][Full Text] [Related]
7. Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease. Kovalevsky A; Gerlits O; Beltran K; Weiss KL; Keen DA; Blakeley MP; Louis JM; Weber IT Methods Enzymol; 2020; 634():257-279. PubMed ID: 32093836 [TBL] [Abstract][Full Text] [Related]
8. Towards investigation of the inhibitor-recognition mechanisms of drug-target proteins by neutron crystallography. Kuroki R; Okazaki N; Adachi M; Ohhara T; Kurihara K; Tamada T Acta Crystallogr D Biol Crystallogr; 2010 Nov; 66(Pt 11):1126-30. PubMed ID: 21041926 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555 [TBL] [Abstract][Full Text] [Related]
10. A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease. Vega S; Kang LW; Velazquez-Campoy A; Kiso Y; Amzel LM; Freire E Proteins; 2004 May; 55(3):594-602. PubMed ID: 15103623 [TBL] [Abstract][Full Text] [Related]
11. A phenylnorstatine inhibitor binding to HIV-1 protease: geometry, protonation, and subsite-pocket interactions analyzed at atomic resolution. Brynda J; Rezacova P; Fabry M; Horejsi M; Stouracova R; Sedlacek J; Soucek M; Hradilek M; Lepsik M; Konvalinka J J Med Chem; 2004 Apr; 47(8):2030-6. PubMed ID: 15056001 [TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. Hou T; Yu R J Med Chem; 2007 Mar; 50(6):1177-88. PubMed ID: 17300185 [TBL] [Abstract][Full Text] [Related]
13. Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations. Chen J; Liang Z; Wang W; Yi C; Zhang S; Zhang Q Sci Rep; 2014 Nov; 4():6872. PubMed ID: 25362963 [TBL] [Abstract][Full Text] [Related]
14. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions. Seibold SA; Cukier RI Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840 [TBL] [Abstract][Full Text] [Related]
15. Crystallization and preliminary neutron diffraction studies of HIV-1 protease cocrystallized with inhibitor KNI-272. Matsumura H; Adachi M; Sugiyama S; Okada S; Yamakami M; Tamada T; Hidaka K; Hayashi Y; Kimura T; Kiso Y; Kitatani T; Maki S; Yoshikawa HY; Adachi H; Takano K; Murakami S; Inoue T; Kuroki R; Mori Y Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):1003-6. PubMed ID: 18997326 [TBL] [Abstract][Full Text] [Related]
16. Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir. Tie Y; Kovalevsky AY; Boross P; Wang YF; Ghosh AK; Tozser J; Harrison RW; Weber IT Proteins; 2007 Apr; 67(1):232-42. PubMed ID: 17243183 [TBL] [Abstract][Full Text] [Related]
17. Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV-1 protease dimer/saquinavir complex. Prashar V; Bihani SC; Das A; Rao DR; Hosur MV Biochem Biophys Res Commun; 2010 Jun; 396(4):1018-23. PubMed ID: 20471372 [TBL] [Abstract][Full Text] [Related]